AbbVie Inc. (NYSE: ABBV) announced a definitive agreement to acquire a device manufacturing facility in Tempe, Arizona from West Pharmaceutical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE